Outpatient CAR T therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Olalekan O. Oluwole
Advertisement
Oluwole is an associate professor of medicine in the Division of Hematology Oncology, Department of Medicine, at Vanderbilt University Medical Center, where he specializes in the treatment of malignant hematologic disorders. He also works at the Vanderbilt Hematology Clinic, which is part of the Vanderbilt-Ingram Cancer Center.
Articles by Olalekan O. Oluwole
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and leukemia.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
2
Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer
3
Stage 1 Multiple Myeloma Treatment Options and Side Effect Management
4
Trodelvy Plus Keytruda Upholds Quality of Life in TNBC
5
